Jazz Pharmaceuticals JAZZ Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| —— | —— | -$368.44M+9.0% | -$404.8M-184% | $482.24M-13.9% | ||
| $40.34M-3.1% | $41.64M-0.2% | $41.72M+5.3% | $39.62M+11.6% | $35.5M+8.4% | ||
| $297.93M+2.3% | $291.13M+0.2% | $290.47M+10.8% | $262.1M+3.1% | $254.3M+2.5% | ||
| $1.33B-1.6% | $1.36B-2.6% | $1.39B+5.8% | $1.32B-15.6% | $1.56B+11.6% | ||
| $64.55M+9.9% | $58.75M+6.2% | $55.31M+8.6% | $50.92M+13.0% | $45.07M+18.4% | ||
| -$1.22B+19.3% | -$1.51B-13.4% | -$1.33B— | —— | —— | ||
| -$213.82M+77.5% | -$948.82M— | —— | —— | —— | ||
| —— | —— | —— | -$165.92M-140% | $418.48M-53.8% | ||
| $1.27B-2.1% | $1.3B-3.0% | $1.34B+5.7% | $1.27B-16.4% | $1.51B+11.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Jazz Pharmaceuticals generate?
- Jazz Pharmaceuticals (JAZZ) generated $1.3B in operating cash flow over the trailing twelve months.
- What is Jazz Pharmaceuticals's free cash flow?
- After $64.6M of capital expenditures, Jazz Pharmaceuticals's free cash flow was $1.3B over the trailing twelve months, down 16.1% year over year.
- Where does Jazz Pharmaceuticals's cash flow data come from?
- Every line is extracted from Jazz Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
